Oncology

Technology is continually enabling less invasive and more targeted cancer treatments. We specialize in modern, non-radiative cancer therapies. We offer our clients extensive expertise in treating prostate cancer, bladder cancer, bone cancer, and numerous soft tissue cancers.

Cancer treatment is advancing massively, with a global trend toward more individualized, non-invasive, and patient-friendly approaches. ProMedical is a pioneer in the market for carefully selected non-radiative cancer treatments. One of the most promising new methods is HIFU (High-Intensity Focused Ultrasound), which has shown globally encouraging research results, particularly in the treatment of prostate and gynecological cancers. We represent EDAP TMS solutions in HIFU technology (NASDAQ: EDAP), a world leader in therapeutic ultrasound with over 35 years of market presence. EDAP TMS develops and manufactures minimally invasive ultrasound-based medical devices, with a primary focus on urology. By continuously investing in research and development in collaboration with INSERM, EDAP TMS has built a robust and valuable patent portfolio grounded in innovative technologies. EDAP TMS’s Focal One solution is already in use in Finland.

For bladder cancer treatment, we offer the EMDA (Electro Motive Drug Administration) solution by Physion, designed specifically for treating superficial high-risk bladder cancer. EMDA uses ionization to deliver medication deeper and more effectively into the targeted tissue. This method has demonstrated superior outcomes, effectively preventing the division of cancer cells or their progression into more malignant forms. EMDA is widely researched and proven effective in all studies for treating high-risk superficial bladder cancer. The technology is in use in Finland, with a national clinical study currently underway.

For bone and soft tissue cancer treatments, through our partnership with Surgnova, we provide alternative ablation solutions. Surgnova’s Dophi™ Tumor Ablation Platform offers solutions for radiofrequency, microwave, and electroporation ablations. The Surgnova range includes the broadest selection of antenna sizes on the market, making the equipment highly versatile and suitable for ablating various types of tumors.